NCT04293562 2026-02-24
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Oncology Group
Phase 3 Recruiting
Children's Oncology Group
Children's Oncology Group
European Society for Blood and Marrow Transplantation
Dutch Childhood Oncology Group
St. Jude Children's Research Hospital